A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken with Rosuvastatin

Trial Identifier: 15994
Sponsor: AstraZeneca
Collaborator:
Eli Lilly and Company
NCTID:: NCT03019549
Start Date: January 2017
Primary Completion Date: May 2017
Study Completion Date: May 2017
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United States, Florida Daytona Beach, Florida, United States, 32117